Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier
Citation
Bentham , P , Staff , R T , Schelter , B O , Shiells , H , Harrington , C R & Wischik , C M 2021 , ' Long-term hydromethylthionine treatment is associated with delayed clinical onset and slowing of cerebral atrophy in a pre-symptomatic P301S MAPT mutation carrier ' , Journal of Alzheimer's Disease , vol. 83 , no. 3 , pp. 1017-1023 . https://doi.org/10.3233/JAD-210390
Rights
© 2021 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). https://creativecommons.org/licenses/by/4.0/